SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada
- Status
- COMPLETED
- Phase
- N/A
Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)
- Status
- COMPLETED
- Phase
- PHASE1
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
- Status
- RECRUITING
- Phase
- PHASE3
LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT
- Status
- UNKNOWN
- Phase
- N/A
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Abequolixron (RGX-104) and Durvalumab in Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Emulation of the KEYNOTE-189 Trial Using Electronic Health Records
- Status
- COMPLETED
- Phase
- N/A
The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC
- Status
- COMPLETED
- Phase
- NA
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
- Status
- RECRUITING
- Phase
- PHASE3
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Status
- RECRUITING
- Phase
- PHASE1